IVDR

EU MDR / IVDR Regulation

Navigating the EU MDR and IVDR: Ensuring Compliance in an Evolving Regulatory Landscape

By now, you’ve likely encountered discussions surrounding the EU Medical Device Regulation (EU MDR) and the EU In-Vitro Diagnostic Regulation (EU IVDR). These regulations represent a significant shift in the European regulatory framework, introducing more rigorous requirements for medical devices and in-vitro diagnostics to ensure patient safety, product transparency, and post-market surveillance.

The EU MDR, effective May 26, 2021, and the EU IVDR, effective May 26, 2022, have fundamentally reshaped the compliance landscape. All manufacturers wishing to place their devices on the European market must now fully adhere to these updated regulations.

Key Changes Under the EU MDR and IVDR:

  1. Increased Focus on Clinical Evidence:
    • Both MDR and IVDR demand robust clinical data to demonstrate product safety and performance.
    • Manufacturers must provide clinical evaluation reports (CERs) for medical devices and performance evaluation reports (PERs) for IVDs.
  2. Risk Management Alignment with Labeling:
    • Residual risks identified in your Risk Management Profile must now be explicitly reflected in your product’s labeling.
    • This ensures that end-users are informed about potential risks and mitigations associated with the product.
  3. Post-Market Surveillance (PMS) and Vigilance:
    • Manufacturers are required to maintain proactive PMS systems and submit Periodic Safety Update Reports (PSURs).
    • Vigilance reporting timelines have been tightened, demanding faster responses to adverse events.
  4. Unique Device Identification (UDI):
    • Devices must now have Unique Device Identifiers (UDI) for better traceability throughout the supply chain.
  5. More Stringent Requirements for Technical Documentation:
    • Technical files must now be far more detailed, structured, and regularly updated.
  6. Classification Changes for IVDs:
    • Under IVDR, many in-vitro diagnostic devices have been reclassified into higher-risk categories, requiring Notified Body involvement where it wasn’t previously necessary.

The Reality of IVDR Compliance:

While approximately 65% of the EU IVDR requirements overlap with the older In-Vitro Diagnostic Directive (IVDD), the IVDR is far more prescriptive. It specifies not just what evidence is required but also how it must be presented and justified.

For example:

  • Are residual risks identified in your medical device risk profile explicitly stated in your labeling? Under IVDR, this is no longer optional—it’s mandatory.
  • Performance Evaluation Plans (PEP) and Performance Evaluation Reports (PER) must now meet stringent evidence standards.

How RQMIS Can Support Your EU MDR and IVDR Compliance:

  • Gap Assessments: Evaluate your current documentation and systems against MDR/IVDR requirements.
  • Technical Documentation Support: Develop and update technical files to align with MDR/IVDR standards.
  • Clinical and Performance Evaluation Reports (CERs & PERs): Prepare evidence-based reports that meet the expectations of Notified Bodies.
  • Risk Management and Labeling Alignment: Ensure residual risks are clearly identified and communicated in product labeling.
  • Post-Market Surveillance (PMS) Plans: Establish and implement proactive PMS and PMCF (Post-Market Clinical Follow-Up) systems.
  • Regulatory Submission Preparation: Facilitate submission processes with Notified Bodies, including audits and conformity assessments.

Why Choose RQMIS?

With deep expertise in EU regulatory frameworks and a team experienced in working directly with Notified Bodies, RQMIS offers tailored strategies to:

  • Simplify your transition to MDR and IVDR compliance.
  • Ensure your product documentation meets current requirements.
  • Minimize approval delays and regulatory risks.

Don’t let the complexity of the EU MDR and IVDR slow your progress. Partner with RQMIS to navigate these regulations confidently, ensuring compliance, patient safety, and market success.

Let’s build a regulatory strategy that ensures your product is not just compliant, but market-ready and resilient in an ever-changing regulatory landscape.

Call us today at (978) 358-7307, or just click here:

Email Us